{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:02:39Z","timestamp":1791846159796,"version":"4.3.4"},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hyperprolactinemia is a common biochemical finding detected in primary care, and guidelines suggest confirmation with a second prolactin measurement to rule out spurious elevation prior to further workup. Premature magnetic resonance imaging (MRI) is a costly potential consequence of improperly worked-up hyperprolactinemia. We aimed to quantify the proportion of prematurely ordered MRI for isolated hyperprolactinemia without confirmation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective chart review was performed between 2012\u20132021 in Alberta, Canada. We identified cases of mildly elevated serum prolactin (&lt;100mcg\/L, females \u226525.0mcg\/L, males \u226521.0mcg\/L) in patients &gt;18 years who underwent MRI brain or sella following prolactin measurement. MRI was classified as \u201cclinically appropriate\u201d or \u201cpremature\u201d based on clinical indication. Clinically appropriate and premature groups were compared based on patient age, sex, and scan year.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 1,730 cases meeting inclusion criteria with a single prolactin measurement prior to MRI; over half (56.1%, n\u2009=\u2009970) were categorized as \u201cpremature.\u201d Of the MRIs in the premature cohort, 39.4% (n\u2009=\u2009382) reported at least one abnormal finding, most commonly microadenoma (n\u2009=\u2009200). There was no statistically significant difference between premature and clinically appropriate groups for patient sex (p\u2009=\u20090.12) or year of MRI (p\u2009=\u20090.35), but patients in the premature group were significantly older (p\u2009&lt;\u20090.01, mean difference 1.52 years, 95% CI:[0.45,2.49]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MRI for investigation of mild hyperprolactinemia is often ordered prematurely without confirmation by repeat prolactin level and generates incidental findings of uncertain clinical significance to the presenting issue. To reduce patient stress and healthcare system burden, providers should ensure proper workup of hyperprolactinemia with repeat prolactin measurement prior to ordering MRI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0346134","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T17:35:31Z","timestamp":1775669731000},"page":"e0346134","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Premature utilization of MRI in the workup of mild hyperprolactinemia"],"prefix":"10.1371","volume":"21","author":[{"given":"Jennifer A.","family":"Mann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Galloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Ghaznavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J. T.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lysack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3140-6957","authenticated-orcid":true,"given":"Kirstie","family":"Lithgow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"issue":"2","key":"pone.0346134.ref001","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1210\/jc.2008-0713","article-title":"Changing patterns of the adult growth hormone deficiency diagnosis documented in a decade-long global surveillance database","volume":"94","author":"SM Webb","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"pone.0346134.ref002","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8122203","article-title":"Hyperprolactinaemia","volume":"8","author":"I Samperi","year":"2019","journal-title":"J Clin Med"},{"issue":"6","key":"pone.0346134.ref003","first-page":"575","article-title":"Diagnosis and management of hyperprolactinemia","volume":"169","author":"O Serri","year":"2003","journal-title":"CMAJ"},{"issue":"2","key":"pone.0346134.ref004","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"S Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"pone.0346134.ref005","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","article-title":"Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement","volume":"19","author":"S Petersenn","year":"2023","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"pone.0346134.ref006","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1210\/jcem-73-6-1289","article-title":"Pulsatile prolactin secretion in hyperprolactinemia due to presumed pituitary stalk interruption","volume":"73","author":"MH Samuels","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"pone.0346134.ref007","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/BF03346388","article-title":"Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients","volume":"31","author":"L Vilar","year":"2008","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"pone.0346134.ref008","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1515\/cclm-2015-0484","article-title":"A possible cause of the variable detectability of macroprolactin by different immunoassay systems","volume":"54","author":"N Hattori","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"pone.0346134.ref009","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejim.2016.07.012","article-title":"Prevalence and predictors of hyperprolactinemia in subclinical hypothyroidism","volume":"35","author":"LK Sharma","year":"2016","journal-title":"Eur J Intern Med"},{"issue":"6","key":"pone.0346134.ref010","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00431-025-06200-x","article-title":"Hyperprolactinemia in children and adolescents: clinical characteristics and etiological spectrum","volume":"184","author":"F Kilci","year":"2025","journal-title":"Eur J Pediatr"},{"key":"pone.0346134.ref011","doi-asserted-by":"crossref","first-page":"1245106","DOI":"10.3389\/fendo.2023.1245106","article-title":"The prevalence of thyroid dysfunction and hyperprolactinemia in women with PCOS","volume":"14","author":"K van der Ham","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"14","key":"pone.0346134.ref012","article-title":"Workup of hyperprolactinemia","volume":"197","author":"JA Mann","year":"2025","journal-title":"CMAJ"},{"issue":"10","key":"pone.0346134.ref013","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-120-10-199405150-00001","article-title":"Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population","volume":"120","author":"WA Hall","year":"1994","journal-title":"Ann Intern Med"},{"issue":"2","key":"pone.0346134.ref014","article-title":"Prospective Evaluation of Incidental Pituitary Imaging Findings in the Sella Turcica","volume":"5","author":"M Kuo","year":"2020","journal-title":"J Endocr Soc"},{"issue":"1","key":"pone.0346134.ref015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/ejendo\/lvad070","article-title":"Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortium","volume":"189","author":"R Hamblin","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"pone.0346134.ref016","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1210\/jc.2010-1048","article-title":"Pituitary incidentaloma: an endocrine society clinical practice guideline","volume":"96","author":"PU Freda","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0346134.ref017","unstructured":"CPSA Physician Directory: College of Physicians & Surgeons of Alberta. [cited 2024 January]. Available from: https:\/\/search.cpsa.ca"},{"issue":"2","key":"pone.0346134.ref018","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s12020-025-04176-0","article-title":"Etiology, presentation, and outcomes of hyperprolactinemia due to pituitary masses in children and adolescents","volume":"88","author":"F Kilci","year":"2025","journal-title":"Endocrine"},{"key":"pone.0346134.ref019","unstructured":"Physician resources in Alberta quarterly update: July 1, 2021 to September 30, 2021. 2021."},{"issue":"1","key":"pone.0346134.ref020","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1186\/s12913-019-4773-y","article-title":"A national intervention to reduce imaging for low back pain by general practitioners: a retrospective economic program evaluation using Medicare Benefits Schedule data","volume":"19","author":"T Morgan","year":"2019","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"pone.0346134.ref021","doi-asserted-by":"crossref","DOI":"10.9778\/cmajo.20160073","article-title":"Implementation of an intervention to reduce population-based screening for vitamin D deficiency: a cross-sectional study","volume":"5","author":"C Naugler","year":"2017","journal-title":"CMAJ Open"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0346134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T17:35:35Z","timestamp":1775669735000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0346134"}},"subtitle":[],"editor":[{"given":"Melissa Orlandin","family":"Premaor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0346134","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]}}}